Abstract
In recent years, a dramatic increase in the prevalence of Escherichia coli strains producing extended-spectrum β-lactamases (ESBLs) has been observed — both in the community and in healthcare settings. This multicentric study aimed to characterize ESBLs produced by E. coli isolates causing hospital-onset and community urinary tract infections, as well as to compare their antimicrobial sensitivity patterns, β-lactamase content and plasmid types. Phenotypic tests for the detection of ESBLs and plasmid-mediated AmpC β-lactamases were initially pursued, followed by molecular detection of resistance genes, plasmid characterization, genotyping with pulsed-field gel electrophoresis and whole genome sequencing (WGS). The isolates exhibited high level of resistance to expanded-spectrum cephalosporins (ESC) and carried CTX-M (cefotaximase-Munich) or TEM (Temoniera) β-lactamases. All six representative isolates subjected to WGS belonged to the widespread clone ST131. In conclusion, our study demonstrated dissemination of group 1 CTX-M positive E. coli in different geographic regions of Croatia, but also different components of the health care systems (hospitals, nursing homes and the community) and confirmed the switch from SHV-2 (suphydril variant) and SHV-5 ESBLs to the nation-wide predominance of group 1 CTX-M β-lactamases. Different plasmids were shown to be associated with the dissemination of blaCTX-M genes in different geographic regions of Croatia.
Similar content being viewed by others
References
Aktaş E, Otlu B, Erdemir D, Ekici H, Bulut E (2017) A first insight into Escherichia coli ST131 high-risk clone among extended-spectrum beta-lactamase-producing urine isolates in Istanbul with the use of matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry and real-time PCR. Microb Drug Resist 23:1032–1036. https://doi.org/10.1089/mdr.2017.0021
Alqasim A, Abu Jaffal A, Alyousef AA (2018) Prevalence of multidrug resistance and extended-spectrum β-lactamase carriage of clinical uropathogenic Escherichia coli iolates in Riyadh, Saudi Arabia. Int J Microbiol 3026851. https://doi.org/10.1155/2018/3026851
Arlet G, Brami G, Décrè D, Flippo A, Gaillot O, Lagrange PH, Philippon A (1995) Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. FEMS Microbiol Lett 134:203–208. https://doi.org/10.1111/j.1574-6968.1995.tb07938.x
Asadi Karam MR, Habibi M, Bouzari S (2019) Urinary tract infection: pathogenicity, antibiotic resistance and development of effective vaccines against uropathogenic Escherichia coli. Mol Immunol 108:56–67. https://doi.org/10.1016/j.molimm.2019.02.007
Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA (2012) SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. https://doi.org/10.1089/cmb.2012.0021
Bedenić B, Vraneš J, Bošnjak Z, Marijan T, Mlinarić-Džepina A, Kukovec T, Anušić M, Beader N, Barl P, Leskovar V, Kalenić S (2010) Emergence of CTX-M group 1 extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains in the community. Med Glas (Zenica) 7:32–39
Bedenić B, Vraneš J, Hofmann-Thiel S, Tonkić M, Novak A, Bučević-Popovic V, Hoffmann H (2012) Characterization of the extended-spectrum β-lactamases and determination of the virulence factors of uropathogenic Escherichia coli strains isolated from children. Wien Klin Wochenschr 124:504–515. https://doi.org/10.1007/s00508-012-0210-5
Bedenić B, Firis N, Elveđi-Gašparović V, Krilanović M, Matanović K, Štimac I, Luxner J, Vraneš J, Meštrović T, Zarfel G, Grisold A (2016a) Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia. Wien Klin Wochenschr 128:404–413. https://doi.org/10.1007/s00508-016-1005-x
Bedenić B, Sardelić S, Luxner J, Bošnjak Z, Varda-Brkić D, Lukić-Grlić A, Mareković I, Frančula-Zaninović S, Krilanović M, Šijak D, Grisold A, Zarfel G (2016b) Molecular characterization of class B carbapenemases in advanced stage of dissemination and emergence of class D carbapenemases in Enterobacteriaceae from Croatia. Infect Genet Evol 43:74–82. https://doi.org/10.1016/j.meegid.2016.05.011
Bonnet R (2004) Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1–14. https://doi.org/10.1128/AAC.48.1.1-14.2004
Brettin T, Davis JJ, Disz T, Edwards RA, Gerdes S, Olsen GJ, Olson R, Overbeek R, Parrello B, Pusch GD, Shukla M, Thomason JA 3rd, Stevens R, Vonstein V, Wattam AR (2015) Xia F (2015) RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Sci Rep 5:8365. https://doi.org/10.1038/srep08365
Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219–228. https://doi.org/10.1016/j.mimet.2005.03.018
CLSI – clinical laboratory standard institute (2016) performance standards for antimicrobial susceptibility testing; twenty-sixth informational supplement. CLSI document M100-S26. Wayne, PA: Clinical and Laboratory Standards Institute
Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nordmann P (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 14:195–200. https://doi.org/10.3201/eid1402.070350
Coudron PE (2005) Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli and Proteus mirabilis. J Clin Microbiol 43:4163–4167. https://doi.org/10.1128/JCM.43.8.4163-4167.2005
Croxall G, Hale J, Weston V, Manning G, Cheetham P, Achtman M, McNally A (2011) Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J Antimicrob Chemother 66:2501–2508. https://doi.org/10.1093/jac/dkr349
Day MJ, Hopkins KL, Wareham DW, Toleman MA, Elviss N, Randall L, Teale C, Cleary P, Wiuff C, Doumith M, Ellington MJ, Woodford N, Livermore DM (2019) Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study. Lancet infect dis pii: S1473-3099(19)30273-7. https://doi.org/10.1016/S1473-3099(19)30273-7
Elwell LP, Falkow S (1986) The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian V (ed) Antibiotics in laboratory medicine, 2nd edn. Williams and Wilkins, Baltimore MD, pp 683–721
Ferjani S, Saidani M, Ennigrou S, Hsairi M, Slim AF, Ben Boubaker IB (2014) Multidrug resistance and high virulence genotype in uropathogenic Escherichia coli due to diffusion of ST131 clonal group producing CTX-M-15: an emerging problem in a Tunisian hospital. Folia Microbiol (Praha) 59:257–262. https://doi.org/10.1007/s12223-013-0292-0
Gonçalves D, Cecílio P, Ferreira H (2016) Nursing homes and long-term care facilities: reservoirs of CTX-M-15-producing Escherichia coli O25b-ST131 in Portugal. J Glob Antimicrob Resist 7:69–71. https://doi.org/10.1016/j.jgar.2016.08.001
Gurevich A, Saveliev V, Vyahhi N, Tesler G (2013) QUAST: quality assessment tool for genome assemblies. Bioinformatics 29:1072–1075. https://doi.org/10.1093/bioinformatics/btt086
Hanson ND, Moland ES, Hong SG, Propst K, Novak DJ, Cavalieri SJ (2008) Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob Agents Chemother 52:3814–3816. https://doi.org/10.1128/AAC.00877-08
Hayakawa K, Nagamatsu M, Mezaki K, Sugiki Y, Kutsuna S, Takeshita N, Yamamoto K, Mawatari M, Fujiya Y, Ohmagari N (2017) Epidemiology of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli in Japan: characteristics of community-associated versus healthcare-associated ESBL E. coli. J Infect Chemother 23:117–119. https://doi.org/10.1016/j.jiac.2016.08.010
Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867–878. https://doi.org/10.1093/clinids/10.4.867
Kagia N, Kosgei P, Ooko M, Wafula L, Mturi N, Anampiu K, Mwarumba S, Njuguna P, Seale AC, Berkley JA, BottomLey C, Scott JAG, Morpeth SC (2019) Carriage and Acquisition of Extended-spectrum β-lactamase-producing Enterobacterales among neonates admitted to Hospital in Kilifi, Kenya. Clin infect dis pii:ciy976. https://doi.org/10.1093/cid/ciy976
Kardaś-Słoma L, Lucet JC, Perozziello A, Pelat C, Birgand G, Ruppé E, Boëlle PY, Andremont A, Yazdanpanah Y (2017) Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis. BMJ Open 7:e017402. https://doi.org/10.1136/bmjopen-2017-017402
Kaufman ME (1998) Pulsed-field gel electrophoresis. In: Woodford N, Johnsons a (eds) molecular bacteriology. Protocols and clinical applications, 1st edn. Humana press Inc., Totowa, New York, pp 33–51
Kleinheinz KA, Joensen KG, Larsen MV (2014) Applying the ResFinder and VirulenceFinder web-services for easy identification of acquired antibiotic resistance and E. coli virulence genes in bacteriophage and prophage nucleotide sequences. Bacteriophage 4:e27943. https://doi.org/10.4161/bact.27943
Literacka E, Bedenić B, Baraniak A, Fiett J, Tonkić M, Jajić-Benčić I, Gniadkowski M (2009) BlaCTX-M genes in Escherichia coli from Croatian hospitals are located in new (blaCTX-M-3) and widely spread (blaCTX-M-3a, blaCTX-M-15) genetic structures. Antimicrob Agents Chemother 53:1630–1635. https://doi.org/10.1128/AAC.01431-08
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
Marijan T, Plećko V, Vraneš J, Džepina AM, Bedenić B, Kalenić S (2010) Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urine of nonhospitalized patients in the Zagreb region. Med Glas (Zenica) 7:46–53
Merino I, Shaw E, Horcajada JP, Cercenado E, Mirelis B, Pallarés MA, Gómez J, Xercavins M, Martínez-Martínez L, De Cueto M, Cantón R, Ruiz-Garbajosa P, ITUBRAS-GEIH-SEIMC Group (2016) CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain. J Antimicrob Chemother 71:2125–2130. https://doi.org/10.1093/jac/dkw133
Nabti LZ, Sahli F, Radji N, Mezaghcha W, Semara L, Aberkane S, Lounnas M, Solassol J, Didelot MN, Jean-Pierre H, Dumont Y, Godreuil S (2019) High prevalence of multidrug-resistant Escherichia coli in urine samples from inpatients and outpatients at a tertiary care hospital in Sétif, Algeria. Microb Drug Resist 25:386–393. https://doi.org/10.1089/mdr.2018.0314
Nüesch-Inderbinen MT, Hächler H, Kayser FH (1996) Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis 15:398–402. https://doi.org/10.1007/BF01690097
Pagani L, Mantengoli E, Migliavacca R, Nucleo E, Pollini S, Spalla M, Daturi R, Romero E, Rossolini GM (2004) Multifocal detection of multidrugresistant Pseudomonas aeruginosa producing PER-1 extended-spectrum β-lactamase in Northern Italy. J Clin Microbiol 42:2523–9. https://doi.org/10.1128/JCM.42.6.2523-2529.2004
Park SH, Byun JH, Choi SM, Lee DG, Kim SH, Kwon JC, Park C, Choi JH, Yoo JH (2012) Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect Dis 12:149. https://doi.org/10.1186/1471-2334-12-149
Pérez-Pérez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153–62.
Pitout JD, Laupland KB (2008) Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159–166. https://doi.org/10.1016/S1473-3099(08)70041-0
Pitout JD, Nordmann P, Laupland KB, Poirel L (2005) Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56:52–59. https://doi.org/10.1093/jac/dki166
Poirel L, Madec JY, Lupo A, Schink AK, Kieffer N, Nordmann P, Schwarz S (2018) Antimicrobial Resistance in Escherichia coli. Microbiol Spectr 6. https://doi.org/10.1128/microbiolspec.ARBA-0026-2017
Reuland EA, Al Naiemi N, Kaiser AM, Heck M, Kluytmans JA, Savelkoul PH, Elders PJ, Vandenbroucke-Grauls CM (2016) Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam. J Antimicrob Chemother 71:1076–1082. https://doi.org/10.1093/jac/dkv441
Rodriguez-Baño J, Paterson DL (2006) A change in the epidemiology of infections due to extended-spectrum beta-lactamase-producing organisms. Clin Infect Dis 42:935–937. https://doi.org/10.1086/500945
Rogers BA, Sidjabat HE, Paterson DL (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66:1–14. https://doi.org/10.1093/jac/dkq415
Saladin M, Cao VT, Lambert T, Donay JL, Herrmann JL, Ould-Hocine Z, Verdet C, Delisle F, Philippon A, Arlet G (2002) Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 209:161–168. https://doi.org/10.1111/j.1574-6968.2002.tb11126.x
Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Claeys G, Lontie M, Van Meensel B, Herman L, Haesebrouck F, Butaye P (2010) Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 16:129–134. https://doi.org/10.1089/mdr.2009.0132
Soria Segarra C, Soria Baquero E, Cartelle Gestal M (2018) High prevalence of CTX-M-1-like enzymes in urinary isolates of Escherichia coli in Guayaquil, Ecuador. Microb Drug Resist 24:393–402. https://doi.org/10.1089/mdr.2017.0325
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239
Valenza G, Nickel S, Pfeifer Y, Pietsch M, Voigtländer E, Lehner-Reindl V, Höller C (2017) Prevalence and genetic diversity of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in nursing homes in Bavaria, Germany. Vet Microbiol 200:138–141. https://doi.org/10.1016/j.vetmic.2015.10.008
Vranić-Ladavac M, Bošnjak Z, Beader N, Barišić N, Kalenić S, Bedenić B (2010) Clonal spread of CTX-M-15-producing Klebsiella pneumoniae in a Croatian hospital. J Med Microbiol 59:1069–1078. https://doi.org/10.1099/jmm.0.019778-0
Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore DM (2004) Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 54:735–743. https://doi.org/10.1093/jac/dkh424
Woodford N, Fagan EJ, Ellington MJ (2006) Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother 57:154–155. https://doi.org/10.1093/jac/dki412
Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV (2012) Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. https://doi.org/10.1093/jac/dks261
Acknowledgements
We would like to thank Dr. Maja Anušić for technical assistance with serotyping.
Funding
This work was partly supported by Horizon 2020 project FAPIC (Fast Assay for Pathogen Identification and Characterization). Grant agreement ID: 634137 (funded under H2020-EU.3.1.3).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Krilanović, M., Tomić-Paradžik, M., Meštrović, T. et al. Extended-spectrum beta-lactamases and plasmid diversity in urinary isolates of Escherichia coli in Croatia: a nation-wide, multicentric, retrospective study. Folia Microbiol 65, 649–667 (2020). https://doi.org/10.1007/s12223-019-00769-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-019-00769-1